Clinical trials
Withdrawn Phase 1 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bellicum Pharmaceuticals | 2 |
| City of Hope Medical Center | 2 |
| Agennix | 1 |
| Baylor College of Medicine | 1 |
| Dr. Avichai Shimoni MD | 1 |
| Imperial College London | 1 |
| M.D. Anderson Cancer Center | 1 |
| Medigene AG | 1 |
| National Cancer Institute (NCI) | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 13 |
| Lymphoma | 4 |
| Leukemia | 3 |
| Myelodysplastic Syndromes | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Multiple Myeloma | 2 |
| Myeloproliferative Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Central Nervous System Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.